RU95106812A - Method of alcoholism treatment - Google Patents

Method of alcoholism treatment

Info

Publication number
RU95106812A
RU95106812A RU95106812/14A RU95106812A RU95106812A RU 95106812 A RU95106812 A RU 95106812A RU 95106812/14 A RU95106812/14 A RU 95106812/14A RU 95106812 A RU95106812 A RU 95106812A RU 95106812 A RU95106812 A RU 95106812A
Authority
RU
Russia
Prior art keywords
alcohol
intoxication
dose
medicine
stages
Prior art date
Application number
RU95106812/14A
Other languages
Russian (ru)
Other versions
RU2114643C1 (en
Inventor
А.Ю. Магалиф
А.А. Магалиф
Original Assignee
А.Ю. Магалиф
А.А. Магалиф
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by А.Ю. Магалиф, А.А. Магалиф filed Critical А.Ю. Магалиф
Priority to RU95106812A priority Critical patent/RU2114643C1/en
Publication of RU95106812A publication Critical patent/RU95106812A/en
Application granted granted Critical
Publication of RU2114643C1 publication Critical patent/RU2114643C1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

FIELD: medicine, narcology. SUBSTANCE: method involves prevention of intoxication, repeated attraction for alcohol and dipsomania by restriction of alcohol intake with dose 30-50 g 96% ethyl alcohol per 24 h, for 3-4 h at interval 3-4 days, not less. Method can be used for patient treatment suffering with chronic alcoholism of 1-st and 2-d stages at ambulatory conditions. Method provides prolonged remissions. EFFECT: improved effectiveness of method.

Claims (1)

Изобретение относится к медицине, а именно к наркологии. Целью: увеличение продолжительности ремиссий за счет предупреждения опьянения, вторичного влечения к алкоголю и запоев ограничивают прием алкоголя дозой 30 - 50 г в сутки 96% этилового спирта в течение 3 - 4 ч с интервалом не менее 3 - 4 сут. Способ может быть использован для лечения больных хроническим алкоголизмом 1 и 2 стадий в амбулаторных условиях.The invention relates to medicine, namely to addiction. Objective: to increase the duration of remissions due to the prevention of intoxication, secondary attraction to alcohol and binges limit the intake of alcohol with a dose of 30-50 g per day of 96% ethyl alcohol for 3-4 hours with an interval of at least 3-4 days. The method can be used to treat patients with chronic alcoholism of stages 1 and 2 on an outpatient basis.
RU95106812A 1995-04-27 1995-04-27 Method of treating for alcoholism RU2114643C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95106812A RU2114643C1 (en) 1995-04-27 1995-04-27 Method of treating for alcoholism

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95106812A RU2114643C1 (en) 1995-04-27 1995-04-27 Method of treating for alcoholism

Publications (2)

Publication Number Publication Date
RU95106812A true RU95106812A (en) 1997-02-27
RU2114643C1 RU2114643C1 (en) 1998-07-10

Family

ID=20167233

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95106812A RU2114643C1 (en) 1995-04-27 1995-04-27 Method of treating for alcoholism

Country Status (1)

Country Link
RU (1) RU2114643C1 (en)

Also Published As

Publication number Publication date
RU2114643C1 (en) 1998-07-10

Similar Documents

Publication Publication Date Title
DE69622265D1 (en) TRICYCLIC COMPOUNDS FOR THE TREATMENT OF CELL PROLIFERATIVE DISORDERS
RU94041950A (en) Use of compounds of 3-arylhydroxypropylamine order for enuresis treatment
MX9707197A (en) Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases.
CA2217499A1 (en) Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
RU94045825A (en) Use of material obtained from mycobacterium vaccae for production of therapeutic agent used for psychiatric disease treatment, method of psychiatric disease treatment, product containing antigenic and/or immunoregulating material, pharmaceutical agent
DE59605959D1 (en) Use of immunoglobulin preparations for the manufacture of a medicament for oral administration for the treatment and prophylaxis of chronic pain conditions
RU95106812A (en) Method of alcoholism treatment
AU3308099A (en) Method for the treatment of pain, including chronic and female specific pain
RU2107489C1 (en) Composition for treatment of inflammatory process in parodontium
EP0495998A4 (en)
RU95104771A (en) Method of treating exacerbating chronic parodontites
RU95105239A (en) Method of sanitation of staphylococcus bacterium carrier
SU1465052A1 (en) Method of prophylaxis and treatment of helminth infestation of animals
SU981254A1 (en) Process for biologically purifying water reservoirs from enteropathogenic bacteriaprocess for biologically purifying water reservoirs from enteropathologenic bacteria
SU1748827A1 (en) Method for treating staphylococcus infection
RU2070058C1 (en) Method of chronic bronchitis treatment
Hiramine et al. Blastogenic factor production by guinea pig B lymphocytes stimulated with thymus-dependent antigen
RU95102604A (en) Method for treating intestinal dysbacteriosis
RU95106892A (en) Immune system correction method
Ancelle et al. Single dose treatment trial for non complicated male gonorrheae: Results.
RU94002713A (en) Method for treating children possessing elongated qt interval syndrome
RU94025309A (en) Agent for treatment of patients with metabolic-alimentary obesity form
RU94016196A (en) Method for treating the cases of abdominal typhoid
NO961496L (en) Treatment of allergic diseases with terfenadine carboxylate
RU95104039A (en) Method of vesical disease treatment